Clinical trials: Prostate Cancer (Diagnosis), open to volunteers
Prostate Cancer (Diagnosis)
Prehabilitation to Patients With Prostate Cancer
The goal of this feasibility study is to test a newly developed, multicomponent prehabilitation intervention to patients with prostate cancer, to improve their resilience to treatment side-effects.
- Trial name
- PREPP (NCT07162987)
- Testing
- Prehabilitation
- Where
- 3 sites in Denmark
- Volunteers
- 20 people
- Sponsor
- Odense University Hospital
Prostate Carcinoma, MRI
Exploring the Correlation Between MRI Image Characteristics and Diagnosis, Pathology and Prognosis in Patients With Prostate Lesions
Globally, prostate cancer is the second most common malignant tumor and the fifth leading cause of cancer-related death in men. In China, there will be more than 125,000 new cases of prostate cancer in 2022, ranking sixth in the…
- Conditions
- Prostate Carcinoma, MRI, Diagnosis
- Trial name
- NCT06946771
- Testing
- Advanced MRI parameters for the diagnosis of prostate cancer
- Where
- China
- Volunteers
- 500 people
- Sponsor
- Zhen Li
Prostate Cancer Diagnosis
Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects?
Differences in terms of diagnostic capability and side effects related to the needle caliber used for prostate biopsy sampling in patients with suspected prostate cancer
- Trial name
- TARGET (NCT06420115)
- Testing
- different needle size for prostate biopsy
- Where
- Italy
- Volunteers
- 580 people, healthy volunteers welcome
- Sponsor
- University Hospital Padova
Prostate Cancer (Diagnosis)
Predicting Prostate Cancer in Elderly Men
We aim to analyze whether the "liquid biopsy" model could increase the specificity of detecting men with an aggressive (defined as Gleason score ≥ 7) prostate cancer and thereby reduce the proportion of men who undergo prostate…
- Trial name
- NCT04079699
- Testing
- Liquid Biopsy, Standard biopsy
- Volunteers
- 700 people
- Sponsor
- Odense University Hospital